GMS Ventures & Investments

Holdings History for Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK)

Symbol: OTLK on Nasdaq
Investment type: Equity / Common Stock, par value $0.01 per share
Latest Disclosed Shares Owned: 29,040,929 shares
Security Ownership %: 50%

GMS VENTURES & INVESTMENTS ownership in Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK)

28 May 2025 - GMS VENTURES & INVESTMENTS has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 29,040,929 shares of Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK). This represents 50% ownership of the company. In their previous filing dated 12 Mar 2025, GMS Ventures & Investments had reported owning 16,183,787 shares, indicating an increase of +79%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
GMS VENTURES & INVESTMENTS	50%	+21%	$45,303,849	29,040,929	+12,857,142	+79%	$1.56	13D/A	27 May 2025	28 May 2025, 17:24
SUKHTIAN GHIATH M.	42%	+7.7%	$25,246,708	16,183,787	+3,458,571	+27%	$1.56	13D/A	11 Mar 2025	12 Mar 2025, 21:11
GMS VENTURES & INVESTMENTS	39%		$19,851,337	12,725,216			$1.56	13D/A	17 Jan 2025	22 Jan 2025, 16:17